Rojek A, Kwasiuk K, Obara-Moszyńska M, Kolesińska Z, Niedziela M. Y chromosome in Turner syndrome. Pediatric Endocrinology Diabetes and Metabolism. 2017;23(1):37-41.
APA
Rojek, A., Kwasiuk, K., Obara-Moszyńska, M., Kolesińska, Z., & Niedziela, M. (2017). Y chromosome in Turner syndrome. Pediatric Endocrinology Diabetes and Metabolism, 23(1), 37-41.
Chicago
Rojek, Aleksandra, Karolina Kwasiuk, Monika Obara-Moszyńska, Zofia Kolesińska, and Marek Niedziela. 2017. "Y chromosome in Turner syndrome". Pediatric Endocrinology Diabetes and Metabolism 23 (1): 37-41.
Harvard
Rojek, A., Kwasiuk, K., Obara-Moszyńska, M., Kolesińska, Z., and Niedziela, M. (2017). Y chromosome in Turner syndrome. Pediatric Endocrinology Diabetes and Metabolism, 23(1), pp.37-41.
MLA
Rojek, Aleksandra et al. "Y chromosome in Turner syndrome." Pediatric Endocrinology Diabetes and Metabolism, vol. 23, no. 1, 2017, pp. 37-41.
Vancouver
Rojek A, Kwasiuk K, Obara-Moszyńska M, Kolesińska Z, Niedziela M. Y chromosome in Turner syndrome. Pediatric Endocrinology Diabetes and Metabolism. 2017;23(1):37-41.
Turner syndrome (TS) is an inherited genetic disorder caused by numerical and/or structural chromosome X aberrations occurring at a frequency of 1:1200–1:2500 live-born girls. The most common karyotype is X chromosome monosomy (45,X) (approximately 50–60% of cases). Approximately 5–6% of patients may have abnormal Y chromosome or mosaicism characterized by the coexistence of 45,X cell line with cell line in which all or part of chromosome Y is present. In patients with TS who have all or fragmented genetic material from chromosome Y there is a substantial risk of cancerous lesions in these dysgenetic gonads. This paper stands for the review of the current knowledge on the genetic material of the Y chromosome in TS, especially in view of the risk of developing malignancies such as gonadoblastoma and dysgerminoma.
